Assignments – Germar Betz

Led the global digital transformation implementation project to establish the base for effective and efficient data driven decision making, including capabilities, compliance and technology, for a top European pharma company
Led the program design and launch of a major transformation program for the commercial area of a top US pharma company, with a total of 70 projects and investment volume of USD 250 m
Led the implementation of a new organizational structure and processes for the R&D function of a leading agro science company, covering more than 1100 employees and 50 countries
Led the turn-around analysis and activity planning for several German affiliates of European tier 2 pharmaceutical companies
Led the design and implementation of a commercial restructuring initiative for a tier 2 pharma / biotech company
Strategy development and roll-out planning for an R&D site network optimization of a major agro science company
Post-merger integration for a leading agro science company
Structured the global program to implement key account management for a top pharma company
Defined the strategy, roll-out planning of a global launch excellence function

Structured the change management approach for the optimization of the sales force automation tool for a leading US based pharma company
Diagnostic and recommendation generation to raise acceptance of global best practices in marketing and sales for a top pharma company
Leveraged change management techniques to structure design and implementation of various projects

Analyzed the European portfolio of value based health care initiative for a top biotech company
Led the turn-around analysis and activity planning for several German affiliates of European tier 2 pharmaceutical companies
Scenario definition and quantification for the global portfolio of a top pharma company, with regards to trends in the health care environment
Business model definition for the consumer division of a large medical device company

Led the program design and launch of a major transformation program for the commercial area of a top US pharma company, with a total of 70 projects and investment volume of USD 250 m
Led the optimization of the US shared marketing and sales services organization of a top pharmaceutical company
Led the design and implementation of a commercial shared service organization for a tier 2 pharma / biotech company
Led the strategy development for the German affiliate of a top Asian pharma company with regards to changes in the health care environment
Led the reorganization of the German sales organization for a Biotechnology company

Led the strategy definition and account management structure for the US hospital market for a leading vaccines manufacturer
Structured the global program to implement key account management for a top pharma company

Led the analysis of global pricing and reimbursement trends, prognosing developments for the US health care market and deriving strategies for the pipeline of a major Asian pharma company
Led the assessment of the impact of a US health care reform on an oncology blockbuster drug, including recommendations to mitigate the negative and leverage the positive effects

Led the pre-launch KOL and stakeholder management strategy definition for multiple products and pharma / biotech clients
Led the risk evaluation and contingency plan development for the launch of a CV product
Positioning and strategy definition for the global diabetes portfolio of a top pharma company
Quantified benefits to support inlicensing negotiations fora potential blockbuster diabetes product

Set up the global launch excellence function and designed launch plans and governance models for a top pharma company
Led the design of the performance management (cross-functional, cross-regional) for the global launch of a potential blockbuster drug
Led the creation of a Launch Handbook for a major Asian pharma company
Led the design of a product launch software

Led the program management office for the parallel launch of four drugs (estimated combined peak sales $ 1 bn), leading 10 consultants and 100 client associates
Led the launch management for a relaunch of an inlicensed drug for a major pharma company in the US

Member of the management team of a market research company in the area of stakeholder management, including responsibility for various client projects
Used a variety of primary and secondary market research methodologies in a multitude of assignments, including expert interviews, written and online surveys, focus groups

Led the assessment of the impact of a US health care reform on an oncology blockbuster drug, including recommendations to mitigate the negative and leverage the positive effects
Scenario definition and quantification for the global portfolio of a top pharma company, with regards to trends in the health care environment
Led the analysis of global pricing and reimbursement trends and prognosing developments for the US health care market
Led the development of requirement profiles of local deciders for a leading vaccine manufacturer

Led the development and alignment with the BUs of a business case for a total invest of $ 200m for a commercial optimization
Led the development of scenario analyses of global product portfolios for major pharmaceutical companies
Created multiple business cases for strategies and process improvements

Led the growth strategy definition and execution in marketing and consulting of a young life sciences market research company as manager for Marketing, Consulting & Strategy, deputy for the CEO
Transformation project manager for a leading agroscience company, covering multiple projects and programs in R&D and Commercial

Project management as part of post merger integration initiatives
Defined the post merger integration program management toolset for a top agrochemical company
Prepared documentation, accompanied negotiations and structured post merger integration of a seed business unit for a global agrochemical company

Led the the strategy definition and impelmentation of a seeds business unit turnaround strategy for a top agrochemical company
Led the turn-around analysis and activity planning for several German affiliates of European tier 2 pharmaceutical companies
Post-merger turn-around analysis for a US-based medical device / manufacturing company